A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2014
At a glance
- Drugs Diacerein (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors TWi Pharmaceuticals
- 10 Jun 2017 Biomarkers information updated
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 06 Aug 2012 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History